Oncolytics Biotech
ONCY
#9623
Rank
HK$0.79 B
Marketcap
HK$6.65
Share price
2.50%
Change (1 day)
-28.79%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of March 2026 : HK$3.98 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is HK$3.98 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$4.38 M-25.85%
2024-12-31HK$5.9 M137.24%
2023-12-31HK$2.49 M15.97%
2022-12-31HK$2.14 M-46.39%
2021-12-31HK$4 M63.88%
2020-12-31HK$2.44 M-19.02%
2019-12-31HK$3.01 M
2018-12-31N/A
2006-12-31HK$1 M-0.05%
2005-12-31HK$1 M3.27%
2004-12-31HK$0.96 M8.15%
2003-12-31HK$0.89 M20.67%
2002-12-31HK$0.74 M1.13%
2001-12-31HK$0.73 M-5.83%
2000-12-31HK$0.78 M-3.03%
1999-12-31HK$0.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
HK$340.08 B 8,537,301.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$364.06 B 9,139,270.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
HK$0.39 B 9,786.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
HK$13.22 M 232.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.57 B 3,328,049.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
HK$0.30 B 7,514.17%๐Ÿ‡บ๐Ÿ‡ธ USA